Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 5-hydroxytryptamine and the pulmonary circulation: receptors, transporters and relevance to pulmonary arterial hypertension.

Literature DB >> 10991906

5-hydroxytryptamine and the pulmonary circulation: receptors, transporters and relevance to pulmonary arterial hypertension.

M R MacLean¹, P Herve, S Eddahibi, S Adnot.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2000 PMID： 10991906 PMCID： PMC1572323 DOI： 10.1038/sj.bjp.0703570

Source DB: PubMed Journal: Br J Pharmacol ISSN： 0007-1188 Impact factor: 8.739

× No keyword cloud information.

69 in total

Review 1. Endothelin-1 and serotonin: mediators of primary and secondary pulmonary hypertension?

Authors: M R MacLean
Journal: J Lab Clin Med Date: 1999-08

2. Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers. Evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth.

Authors: C D Cool; J S Stewart; P Werahera; G J Miller; R L Williams; N F Voelkel; R M Tuder
Journal: Am J Pathol Date: 1999-08 Impact factor: 4.307

Review 3. Synergistic interactions between fenfluramine and phentermine.

Authors: P J Wellman; T J Maher
Journal: Int J Obes Relat Metab Disord Date: 1999-07

4. Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension.

Authors: R M Tuder; C D Cool; M W Geraci; J Wang; S H Abman; L Wright; D Badesch; N F Voelkel
Journal: Am J Respir Crit Care Med Date: 1999-06 Impact factor: 21.405

5. 5-Hydroxytryptamine receptors mediating vasoconstriction in pulmonary arteries from control and pulmonary hypertensive rats.

Authors: M R MacLean; G Sweeney; M Baird; K M McCulloch; M Houslay; I Morecroft
Journal: Br J Pharmacol Date: 1996-11 Impact factor: 8.739

Review 6. Cardiopulmonary dysfunction in cirrhosis.

Authors: H Liu; S S Lee
Journal: J Gastroenterol Hepatol Date: 1999-06 Impact factor: 4.029

Review 7. EVE and beyond, retro and prospective insights.

Authors: M Rabinovitch
Journal: Am J Physiol Date: 1999-07

Review 8. Pulmonary hypertension, anorexigens and 5-HT: pharmacological synergism in action?

Authors: M R MacLean
Journal: Trends Pharmacol Sci Date: 1999-12 Impact factor: 14.819

9. Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells. Relationship with the mitogenic action of serotonin.

Authors: S Eddahibi; V Fabre; C Boni; M P Martres; B Raffestin; M Hamon; S Adnot
Journal: Circ Res Date: 1999-02-19 Impact factor: 17.367

10. 5-hydroxytryptamine receptors mediating contraction in human small muscular pulmonary arteries: importance of the 5-HT1B receptor.

Authors: I Morecroft; R P Heeley; H M Prentice; A Kirk; M R MacLean
Journal: Br J Pharmacol Date: 1999-10 Impact factor: 8.739

50 in total

Review 1. New insights into the pathogenesis and treatment of primary pulmonary hypertension.

Authors: N Rudarakanchana; R C Trembath; N W Morrell
Journal: Thorax Date: 2001-11 Impact factor: 9.139

2. Idiopathic pulmonary arterial hypertension: an avian model for plexogenic arteriopathy and serotonergic vasoconstriction.

Authors: Robert F Wideman; Krishna R Hamal
Journal: J Pharmacol Toxicol Methods Date: 2011-01-26 Impact factor: 1.950

Review 3. Today's and tomorrow's imaging and circulating biomarkers for pulmonary arterial hypertension.

Authors: Marjorie Barrier; Jolyane Meloche; Maria Helena Jacob; Audrey Courboulin; Steeve Provencher; Sébastien Bonnet
Journal: Cell Mol Life Sci Date: 2012-03-25 Impact factor: 9.261

4. Effect of short-term organoid culture on the pharmaco-mechanical properties of rat extra- and intrapulmonary arteries.

Authors: Christelle Guibert; Jean Pierre Savineau; Huguette Crevel; Roger Marthan; Eric Rousseau
Journal: Br J Pharmacol Date: 2005-11 Impact factor: 8.739

Review 5. Transglutaminase 2-mediated serotonylation in pulmonary hypertension.

Authors: K C Penumatsa; B L Fanburg
Journal: Am J Physiol Lung Cell Mol Physiol Date: 2013-12-27 Impact factor: 5.464

6. Plasma miR-451 with echocardiography serves as a diagnostic reference for pulmonary hypertension.

Authors: Xiao-Wei Song; Lu-Lu Zou; Ling Cui; Song-Hua Li; Yong-Wen Qin; Xian-Xian Zhao; Qing Jing
Journal: Acta Pharmacol Sin Date: 2018-05-24 Impact factor: 6.150

Review 7. Pulmonary hypertension in obstructive sleep apnea: is it clinically significant? A critical analysis of the association and pathophysiology.

Authors: Cyrus Kholdani; Wassim H Fares; Vahid Mohsenin
Journal: Pulm Circ Date: 2015-06 Impact factor: 3.017